Quantum Biopharma Ltd.

QNTM Healthcare Biotechnology

In the quarter to June 2026, EPS grew 85.5% and free cash flow grew 5.88%, each against the same quarter a year earlier.

2.47 0.24 −8.86%
Market cap
$21.9M
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
n/a
Altman Z
−0.26
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
1.20 0.63 1.07 1.41
Net Debt/EBITDA
4.50 3.53 2.04 1.39
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.47) (1.02) (0.13) (0.22)
Book value per Share
0.92 (0.32) 1.55 1.97
Free Cash Flow
(3.12) (4.56) (0.41) (0.85)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates